State Street’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,858
| Closed | -$62K | – | 3733 |
|
|
2016
Q4 | $62K | Hold |
11,858
| – | – | ﹤0.01% | 3551 |
|
|
2016
Q3 | $56K | Hold |
11,858
| – | – | ﹤0.01% | 3476 |
|
|
2016
Q2 | $48K | Sell |
11,858
-3,800
| -24% | -$14.2K | ﹤0.01% | 3590 |
|
|
2016
Q1 | $49K | Hold |
15,658
| – | – | ﹤0.01% | 3618 |
|
|
2015
Q4 | $71K | Hold |
15,658
| – | – | ﹤0.01% | 3574 |
|
|
2015
Q3 | $74K | Hold |
15,658
| – | – | ﹤0.01% | 3557 |
|
|
2015
Q2 | $112K | Sell |
15,658
-245,108
| -94% | -$1.84M | ﹤0.01% | 3530 |
|
|
2015
Q1 | $2.21M | Buy |
260,766
+8,860
| +4% | +$75.5K | ﹤0.01% | 2989 |
|
|
2014
Q4 | $2.35M | Buy |
251,906
+7,380
| +3% | +$64.2K | ﹤0.01% | 2970 |
|
|
2014
Q3 | $2.04M | Buy |
244,526
+7,313
| +3% | +$67.7K | ﹤0.01% | 3006 |
|
|
2014
Q2 | $2.74M | Buy |
237,213
+1,299
| +0.6% | +$13.3K | ﹤0.01% | 2909 |
|
|
2014
Q1 | $2.99M | Buy |
235,914
+75,232
| +47% | +$972K | ﹤0.01% | 2852 |
|
|
2013
Q4 | $1.74M | Buy |
160,682
+785
| +0.5% | +$9.12K | ﹤0.01% | 3123 |
|
|
2013
Q3 | $1.98M | Buy |
159,897
+9,633
| +6% | +$133K | ﹤0.01% | 3046 |
|
|
2013
Q2 | $2M | Buy |
+150,264
| New | +$1.93M | ﹤0.01% | 2986 |
|
Other funds holding DSCI
State Street's DSCI Position: Q1 2017 in Review
State Street sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 11,858 shares — an estimated $62K sold.
State Street first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $2.99M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- State Street reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- State Street sold 11,858 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $62K.
- State Street first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- State Street's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.99M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on State Street's 13F filing for Q1 2017, filed 15 May 2017.